The Storm After the Calm: A Case of Medetomidine Withdrawal.

R I Med J (2013)Sep 1, 2026 (epub)

Gustavo D Porto, Kira Galeano, William Binder

✦ AI-curated · Sources linked

Case in brief

A 30-year-old woman with a history of intravenous drug use presented to the emergency department exhibiting nausea, vomiting, agitation, and delirium. She required endotracheal intubation for airway protection and further evaluation. Despite maximum sedation, she developed tachycardia and hypertension. Toxicology screening identified medetomidine, a sedative commonly found in illicit fentanyl mixtures.

What made this case unusual

This case highlights the presence of medetomidine, a veterinary sedative, as an adulterant in illicit fentanyl, which is not commonly reported in Rhode Island.

Diagnostic / clinical pearl

Clinicians should consider the possibility of medetomidine exposure in patients presenting with severe agitation and altered mental status, especially in the context of intravenous drug use.

Why it matters

Understanding the emergence of medetomidine in the illicit drug supply is crucial for appropriate management and awareness of potential complications in emergency settings.

Source

Published in R I Med J (2013). This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Emergency Medicine

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.